Abstract
Antipsychotic agents have been used commonly in the treatment of bipolar disorder. This article reviews the evolution of the use of antipsychotic agents and their role in the acute and maintenance treatment of bipolar disorder. The focus is on neuroleptic drugs, the atypical antipsychotic drugs (risperidone and clozapine), and two fo the new atypical antipsychotic drugs that were recently approved.
MeSH terms
-
Acute Disease
-
Antipsychotic Agents / therapeutic use*
-
Benzodiazepines
-
Bipolar Disorder / drug therapy*
-
Bipolar Disorder / prevention & control*
-
Clinical Trials as Topic
-
Clozapine / therapeutic use
-
Delayed-Action Preparations
-
Drug Therapy, Combination
-
Humans
-
Lithium / therapeutic use
-
Olanzapine
-
Pirenzepine / analogs & derivatives
-
Pirenzepine / therapeutic use
-
Psychotic Disorders / drug therapy
-
Risperidone / therapeutic use
-
Treatment Outcome
Substances
-
Antipsychotic Agents
-
Delayed-Action Preparations
-
Benzodiazepines
-
Pirenzepine
-
Lithium
-
Clozapine
-
Risperidone
-
Olanzapine